Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.675 USD | -6.32% | -6.07% | +136.61% |
03:13pm | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
05-08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+136.61% | 666M | |
+27.48% | 44.96B | |
-0.24% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.04% | 26.08B | |
-21.11% | 19.03B | |
+6.23% | 12.75B | |
+28.72% | 12.06B | |
-3.47% | 11.75B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- EF Hutton Initiates Mind Medicine at Buy With $21 Price Target